1 Nikolettos N,Asimakopoulos B,Koster F,et al.Cytokine profile in cases with premature elevation of progesterone serum concentrations during ovarian stimulation.Physiol Res,2008,57:215-224. 2 颜建英,吴新枝,张勤建.血管内皮生长因子和胎盘微血管密度与胎盘植入发病的关系.中华围产医学杂志,2016,19:608-613. 3 Schindler AE.Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders:an outlook.Horm Mol Biol Clin Investig,2016,27:49-53. 4 Irving C,Hertig AT.A study of placenta accreta.Surg Gynecol Obstet,1937,64:178-200. 5 Albrecht ED,Bonagura TW,Burleigh DW,et al.Suppression of extravillous trophoblast invasion of uterine spiral arteries by estrogen during early baboon pregnancy.Placenta,2006,27:483-490. 6 Boroujeni MB,Boroujeni NB,Gholami M.The effect of progesterone treatment after ovarian induction on endometrial VEGF gene expression and its receptors in mice at pre-implantation time.Iran J Basic Med Sci,2016,19:252-257. 7 Tseng JJ,Chou MM.Differential expression of growth-,angiogenesis- and invasion-related factors in the development of placenta accreta.Taiwan J Obstet Gynecol,2006,45:100-106. 8 Chantraine F,Blacher S,Berndt S,et al.Abnormal vascular architecture at the placental-maternal interface in placenta increta.Am J Obstet Gynecol,2012,207:181-188. 9 Choux C,Carmignac V,Bruno C,et al.The placenta:phenotypic and epigenetic modifications induced by Assisted Reproductive Technologies throughout pregnancy.Clin Epigenetics,2015,7:87. 10 Kim SC,Park MJ,Joo BS,et al.Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia.J Obstet Gynaecol Res,2012,38:665-673.
